Iofina (LON:IOF – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Canaccord Genuity Group in a research note issued to investors on Friday, Digital Look reports. They currently have a GBX 70 price objective on the stock. Canaccord Genuity Group’s target price suggests a potential upside of 37.25% from the stock’s current price.
Iofina Stock Performance
Shares of IOF traded down GBX 4 during mid-day trading on Friday, hitting GBX 51. The company’s stock had a trading volume of 2,387,664 shares, compared to its average volume of 535,929. Iofina has a one year low of GBX 20 and a one year high of GBX 60.12. The company has a debt-to-equity ratio of 10.80, a quick ratio of 1.56 and a current ratio of 2.57. The firm has a market capitalization of £97.85 million, a PE ratio of 11.33 and a beta of 0.96. The stock’s 50-day moving average is GBX 52.67 and its two-hundred day moving average is GBX 48.49.
Iofina (LON:IOF – Get Free Report) last announced its earnings results on Monday, September 21st. The company reported GBX 1.80 earnings per share (EPS) for the quarter. Iofina had a net margin of 12.91% and a return on equity of 15.30%. As a group, sell-side analysts anticipate that Iofina will post 1.82 EPS for the current year.
About Iofina
Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.
See Also
- Five stocks we like better than Iofina
- These 3 Green Stocks Have a Growth Story That Goes Far Beyond Washington
- Meta Claims Frontier-Class AI Status With New Muse Wonder Models
- Berkshire Just Backed This Little-Known Stock—Should You Chase It?
- Broadcom’s CEO Sees Years of AI Demand But Warns of a Bigger Threat to the Boom
Receive News & Ratings for Iofina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iofina and related companies with MarketBeat.com's FREE daily email newsletter.
